NCT05794633

Brief Summary

Shoulder pain is highly prevalent within general population, and shoulder impingement syndrome (SIS) is a common cause of shoulder pain. A small number of clinical and methodologically diverse trials have been published recently which show little evidence to support or refute the use of acupuncture for shoulder pain. Some researchers concluded, there is a need for further well-designed clinical trials. Our aim in this study is to investigate the effect of acupuncture treatment on pain, range of motion, functionality and quality of life in patients diagnosed with Subacromial Impingement Syndrome as a result of clinical and radiological tests.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 3, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

September 12, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2024

Completed
Last Updated

September 14, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

March 6, 2023

Last Update Submit

September 12, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain intensity

    All groups will be evaluated for shoulder pain with visual analogue scale (VAS) for rest, activity, and sleep-disturbing.

    2 months

  • Shoulder Pain and Disability Index

    All groups will be evaluated for shoulder function with the Shoulder Pain and Disability Index (SPADI). SPADI:The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. To answer the questions, patients place a mark on a 10cm visual analogue scale for each question. Higher results indicate worse function.

    2 months

  • The Disabilities of the Arm, Shoulder and Hand Score

    All groups will be evaluated for shoulder function with The Disabilities of the Arm, Shoulder and Hand Score (QuickDash). The QuickDASH only contains 11 items. It is a questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms. The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity/function level. Higher results indicate worse function.

    2 months

Secondary Outcomes (2)

  • Shoulder range of motion

    2 months

  • Quality of life index

    2 months

Study Arms (2)

Acupuncture Group

EXPERIMENTAL

The patients will be recieved two days a week for 8 sessions with sterile 25\*40 mm needles.Selected points are as local points, 2 painful points (ahshi point) in the shoulder region, Large intestine 4, 15, Gallbladder 21, Triple warmer 5, 14 Small intestine 9; as distant points Gallbladder 34 and Stomach 38. Patients will recieve also exercise treatment for 8 weeks and coldpack for 4 weeks

Other: Acupuncture

Placebo Acupuncture Group

PLACEBO COMPARATOR

The patients will be recieved two days a week for 8 sessions with placebo needle. Selected points are Large intestine 15 Triple warmer 14 gallbladder 21 and small intestine 9. We will use the Placebo needle (blunt needle, tip obtuse, when acupuncture the feeling is similar to acupuncture needles into the skin, but it retracts instead of piercing the skin) to conduct acupuncture treatment. The retention time will be the same as those in the acupuncture group. The specialist will give the subjects verbal cues before and during the acupuncture manipulation, which further reduces the subjects' doubts about the authenticity of acupuncture in the this group. To ensure the implementation of the blinding method, all patients will be treated independently and avoid contacting with each other. Patients will recieve also exercise treatment for 8 weeks and coldpack for 4 weeks

Other: Placebo acupuncture

Interventions

The patients will be recieved two days a week for 8 sessions with sterile 25\*40 mm needles.Selected points are as local points, 2 painful points (ahshi point) in the shoulder region, Large intestine 4, 15, Gallbladder 21, Triple warmer 5, 14 Small intestine 9; as distant points Gallbladder 34 and Stomach 38. Patients will recieve also exercise treatment for 8 weeks and coldpack for 4 weeks

Acupuncture Group

The patients will be recieved two days a week for 8 sessions with placebo needle. Selected points are Large intestine 15 Triple warmer 14 gallbladder 21 and small intestine 9. We will use the placebo needle (blunt needle, tip obtuse, when acupuncture the feeling is similar to acupuncture needles into the skin, but it retracts instead of piercing the skin) to conduct acupuncture treatment. The retention time will be the same as those in the acupuncture group. The specialist will give the subjects verbal cues before and during the acupuncture manipulation, which further reduces the subjects' doubts about the authenticity of acupuncture in the this group. To ensure the implementation of the blinding method, all patients will be treated independently and avoid contacting with each other. Patients will recieve also exercise treatment for 8 weeks and coldpack for 4 weeks

Placebo Acupuncture Group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Subacromial impingement syndrome
  • Age range from 20-65 years
  • Pain VAS ≥ 4
  • Shoulder impingement symptoms lasting at least 6 weeks

You may not qualify if:

  • Presence of other shoulder pathologies
  • Previous applications of physiotherapy and injection of hyaluronic acid and/or corticosteroid during the preceding 3 months;
  • Presence of cervical pain or other conditions such as fibromyalgia confusing the clinical picture
  • Presence of malignancy, blood disorder, neurologic, motor, and/or sensory deficit in the upper extremity;
  • Pregnancy,
  • Local anesthetic allergy
  • Previous acupuncture treatment
  • History of deformities, fractures, or surgery of the shoulder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Karamanlioglu DS, Kaysin MY, Begoglu FA, Akpinar P, Ozkan FU, Aktas I. Effects of acupuncture on pain and function in patients with subacromial impingement syndrome: A randomized sham-controlled trial. Integr Med Res. 2024 Jun;13(2):101049. doi: 10.1016/j.imr.2024.101049. Epub 2024 May 25.

MeSH Terms

Conditions

Shoulder Impingement Syndrome

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Duygu Silte Karamanlioglu

    Fatih Sultan Mehmet Traning and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Meryem Yilmaz Kaysin

    Fatih Sultan Mehmet Traning and Research Hospital

    STUDY CHAIR
  • Feyza Akan Begoglu

    Fatih Sultan Mehmet Traning and Research Hospital

    STUDY CHAIR
  • Pinar Akpinar

    Fatih Sultan Mehmet Traning and Research Hospital

    STUDY CHAIR
  • Feyza Unlu Ozkan

    Fatih Sultan Mehmet Traning and Research Hospital

    STUDY CHAIR
  • Ilknur Aktas

    Fatih Sultan Mehmet Traning and Research Hospital

    STUDY CHAIR

Central Study Contacts

Duygu Silte Karamanlioglu

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
All patients will be evaluated by the same physiatrist who are blinded to the randomization process and treatment protocols
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized placebo-controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 6, 2023

First Posted

April 3, 2023

Study Start

September 12, 2023

Primary Completion

November 20, 2023

Study Completion

January 20, 2024

Last Updated

September 14, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share